Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

UNITY 2: A Study of an Investigational Treatment Regimen of DCV+ASV+BMS-791325 in a Fixed Dose Combination (the DCV 3DAA (Direct Acting Antiviral) Regimen) With or Without RBV for 12 Weeks for the Treatment of Chronic Hepatitis C Virus(HCV)Genotype 1 Infection in Subjects With Compensated Cirrhosis

ClinicalTrials.gov ID: NCT01973049

Public ClinicalTrials.gov record NCT01973049. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 4:01 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Evaluation of a Daclatasvir/Asunaprevir/BMS-791325 Fixed Dose Combination in Subjects With Genotype 1 Chronic Hepatitis C and Compensated Cirrhosis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To demonstrate the effectiveness of DCV 3DAA fixed dose combination with or without Ribavirin in treatment naive cirrhotic subjects.

Study identification

NCT ID
NCT01973049
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
202 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2013
Primary completion
Jul 31, 2014
Completion
Oct 31, 2014
Last update posted
Oct 8, 2015

2013 – 2014

United States locations

U.S. sites
26
U.S. states
15
U.S. cities
25
Facility City State ZIP Site status
Scripps Clinic La Jolla California 92037
Medical Associates Research Group San Diego California 92123
Quest Clinical Research San Francisco California 94115
University Of Colorado Denver & Hospital Aurora Colorado 80045
Borland-Groover Clinic Jacksonville Florida 32256
Orlando Immunology Center Orlando Florida 32803
Miami Research Associates South Miami Florida 33143
Gastrointestinal Specialists Of Georgia Marietta Georgia 30060
University Of Chicago Chicago Illinois 60637
Indiana University Health Indianapolis Indiana 46202
Kansas City Care Clinic Kansas City Missouri 64111
Kansas City Research Institute Kansas City Missouri 64131
Binghamton Gastroenterology Associates Binghamton New York 13903
Weill Cornell Medical College New York New York 10021
Asheville Gastroenterology Associates, Pa Asheville North Carolina 28801
Duke University Medical Center Durham North Carolina 27710
Carolinas Center For Liver Disease Statesville North Carolina 28677
University Hospitals Case Medical Center Cleveland Ohio 44106
Lehigh Valley Health Network Allentown Pennsylvania 18102
Quality Medical Research Pllc Nashville Tennessee 37211
Advanced Liver Therapies Houston Texas 77030
Texas Liver Institute San Antonio Texas 78215
Mt Vernon Endoscopy Center Alexandria Virginia 22306
Inova Fairfax Hospital Falls Church Virginia 22042
Digestive And Liver Disease Specialists Norfolk Virginia 23502
Dean Clinic Madison Wisconsin 53715

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 23 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01973049, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 8, 2015 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01973049 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →